Shuttle Pharmaceuticals Holdings (SHPH) Cash from Investing Activities (2023 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Cash from Investing Activities of -$36000.0 for Q1 2026, down 102.17% quarter-over-quarter from $1.7 million in Q3 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$36000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$36000.0; the TTM figure through Mar 2026 stood at $2.8 million (changed N/A YoY), while the FY2025 annual figure was -$3.1 million, down 204.83% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$36000.0, down from $1.7 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $1.7 million in Q3 2024, with the low at -$3.0 million in Q1 2023.
- The 3-year median for Cash from Investing Activities is $74920.5 (2023), against an average of $6255.2.
- Peak annual rise in Cash from Investing Activities reached 6506.87% in 2024, while the deepest fall reached 103.43% in 2024.
- Shuttle Pharmaceuticals Holdings' Cash from Investing Activities stood at $87037.0 in 2023, then surged by 1803.21% to $1.7 million in 2024, then tumbled by 102.17% to -$36000.0 in 2026.
- Business Quant data shows SHPH's Cash from Investing Activities at -$36000.0 in Q1 2026, $1.7 million in Q3 2024, and $1.2 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | -36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Sep 30, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 101,295.00 |
| Mar 31, 2024 | 101,295.00 |
| Dec 31, 2023 | 87,037.00 |
| Dec 31, 2023 | 87,037.00 |
| Sep 30, 2023 | -25,855.00 |
| Sep 30, 2023 | -25,855.00 |
| Jun 30, 2023 | 62,804.00 |
| Jun 30, 2023 | 62,804.00 |
| Mar 31, 2023 | -2.95 Mn |
| Mar 31, 2023 | -2.95 Mn |